Advances in Medical Sciences is an international, peer-reviewed journal that welcomes original research articles and reviews on current advances in life sciences, preclinical and clinical medicine, and related disciplines.The Journal’s primary aim is to make every effort to contribute to progress in medical sciences. The strive is to bridge laboratory and clinical settings with cutting edge research findings and new developments.Advances in Medical Sciences publishes articles which bring novel insights into diagnostic and molecular imaging, offering essential prior knowledge for diagnosis and treatment indispensable in all areas of medical sciences. It also publishes articles on pathological sciences giving foundation knowledge on the overall study of human diseases. Through its publications Advances in Medical Sciences also stresses the importance of pharmaceutical sciences as a rapidly and ever expanding area of research on drug design, development, action and evaluation contributing significantly to a variety of scientific disciplines.The journal welcomes submissions from the following disciplines:General and internal medicine,Cancer research,Genetics,Endocrinology,Gastroenterology,Cardiology and Cardiovascular Medicine,Immunology and Allergy,Pathology and Forensic Medicine,Cell and molecular Biology,Haematology,Biochemistry,Clinical and Experimental Pathology.Only review articles from experts in the field will be considered for publication. The journal does not accept case reports.Please see our Guide for Authors for information on article submission.Benefits to authorsWe also provide many author benefits, such as free PDFs, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Advances in Medical Sciences, founded in 1955, is the official journal of the Medical University of Bialystok, Poland.
An official journal of the European Proteomics Association (EuPA)Journal of Proteomics is aimed at protein scientists and analytical chemists in the field of proteomics, biomarker discovery, protein analytics, plant proteomics, microbial and animal proteomics, human studies, tissue imaging by mass spectrometry, non-conventional and non-model organism proteomics, and protein bioinformatics. The journal welcomes papers in new and upcoming areas such as metabolomics, genomics, systems biology, toxicogenomics, pharmacoproteomics.Journal of Proteomics unifies both fundamental scientists and clinicians, and includes translational research. Suggestions for reviews and thematic issues are welcome. All manuscripts are strictly peer reviewed and conform to the highest ethical standards. Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
Trends in Molecular Medicine objective is to provide concise and contextualized views on the latest research moving biomedical science closer to improved diagnosis, treatment, and prevention of human diseases. As such, TMM is dedicated to research disciplines at the interface between basic biology and clinical research. Articles cover new concepts in mechanisms of human biology and pathology with clear implications for diagnostics and therapy. Bridging bench and bedside, reviews published in TMM have clear implications for human health and disease and discuss not only preclinical studies but also research conducted on patient samples, first-in-man studies, and patient-enrolled trials. The major themes covered in TMM in include:Disease mechanismsTools and technologiesDiagnosticsTherapeuticsWe particularly seek articles that are relevant to more than one of these themes. The goal of TMM is to serve as platform for discussion, push the boundaries of traditional clinical or scientific categorization and forge new links between scientists and clinicians. TMM reviews and opinions serve as templates for future explorations in molecular medicine, and to inspire new directions of studies toward improving human health. The journal?s focus is on publishing articles that are provocative and authoritative but also accessible to a broad audience.Furthermore 'medicine' involves a vital societal element; molecular interventions raise controversial ethical, legal and financial issues. TMM also publishes discussions concerning the clinical trial landscape, science policy and medical ethics.All these issues are addressed in TMM in a style that builds on 25 years' experience of publishing the Trends journals.For more information, go to http://www.cell.com/trends/molecular-medicine